The Firm is representing Teleflex Incorporated (“Teleflex”) in connection with the proposed sale of its Acute Care and Interventional Urology businesses to Intersurgical Ltd and its OEM business to private equity firms Montagu and Kohlberg for a combined total of $2.03 billion in cash, subject to certain closing adjustments. The transactions are expected to be completed in the second half of 2026, subject to customary regulatory approvals and other closing conditions.
Teleflex is a leading global provider of medical technologies designed to improve the health and quality of people’s lives and offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access and urology.
The Simpson Thacher team includes Jonathan Corsico, Benjamin Bodurian, John Dougherty, Paul Bolaji, Lawrence Ekin, Victoria Schmit, Dasha Kolyaskina, Darya Kaboli-Nejad and Ella (Yumeng) Zhang (M&A); Roxane Reardon, Matt Hart, Kirsten Harmon, Erin Camia and Jacob Broz (Capital Markets); Vanessa Burrows, Alison Peters and Jacob Madden (Healthcare); Peter Guryan, Étienne Renaudeau and Daniel Owsley (Antitrust); Gillian Emmett Moldowan, Ashlie Lawton, Sara Mazurek and Skyler Kanfer (Executive Compensation and Employee Benefits); Andrew Purcell, Edward Grais and Benjamin Bressler (Tax); Ron Ben-Yehuda, Christian Bond and Xi Pu Fan (Sara) Liu (Intellectual Property); Bill Sheehan, Kyle Nelson, Abdul Fasinro and Sally Jo (Credit); Krista McManus (Real Estate); and Karen Kelley and Brandon Adoni (Public Company Advisory Practice).